JPS5437833A - Pharmaceutical composition for treating high glucagon level disease - Google Patents

Pharmaceutical composition for treating high glucagon level disease

Info

Publication number
JPS5437833A
JPS5437833A JP11726477A JP11726477A JPS5437833A JP S5437833 A JPS5437833 A JP S5437833A JP 11726477 A JP11726477 A JP 11726477A JP 11726477 A JP11726477 A JP 11726477A JP S5437833 A JPS5437833 A JP S5437833A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
treating high
level disease
glucagon level
high glucagon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11726477A
Other languages
English (en)
Inventor
Ritsupuman Uirubaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Canada Inc
Original Assignee
Ayerst Mckenna and Harrison Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna and Harrison Inc filed Critical Ayerst Mckenna and Harrison Inc
Publication of JPS5437833A publication Critical patent/JPS5437833A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP11726477A 1977-07-25 1977-09-28 Pharmaceutical composition for treating high glucagon level disease Pending JPS5437833A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/818,379 US4118495A (en) 1977-07-25 1977-07-25 Method of treating hyperglucagonemia with 1,3-dioxo-1H-benz[de]-isoquinoline-2(3H)-acetic acid

Publications (1)

Publication Number Publication Date
JPS5437833A true JPS5437833A (en) 1979-03-20

Family

ID=25225409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11726477A Pending JPS5437833A (en) 1977-07-25 1977-09-28 Pharmaceutical composition for treating high glucagon level disease

Country Status (4)

Country Link
US (1) US4118495A (ja)
JP (1) JPS5437833A (ja)
BE (1) BE869248A (ja)
ZA (1) ZA783846B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254108A (en) * 1979-11-08 1981-03-03 Ayerst, Mckenna & Harrison Inc. Thioxo-1H-benz[de]isoquinoline-2(3H)-acetic acid derivatives and antidiabetic use thereof
US4254109A (en) * 1979-11-08 1981-03-03 Ayerst, Mckenna & Harrison Inc. 1H-Benz[de]isoquinoline-2(3H)-acetic acid derivatives
US4598081A (en) * 1984-10-12 1986-07-01 Nauchno-Issledovatelsky Institut Endokrinologii I Obmena Veschestv 1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid, pharmacologically acceptable salts thereof and compositions containing the same for treatment of diabetes mellitus complications

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications

Also Published As

Publication number Publication date
ZA783846B (en) 1979-07-25
BE869248A (fr) 1979-01-25
US4118495A (en) 1978-10-03

Similar Documents

Publication Publication Date Title
JPS53109934A (en) Pharmaceutical composition
JPS53113007A (en) Pharmaceutical composition
ZA785682B (en) Pharmaceutical compositions
GB2003028B (en) Pharmaceutical compositions
JPS5484022A (en) Pharmaceutical composition
JPS5449333A (en) Pharmaceutical composition
JPS53133637A (en) Pharmaceutical composition
JPS5417114A (en) Dislanol composition for treating favus disease
PH15193A (en) Pharmaceutical composition
GB2021409B (en) Pharmaceutical composition
GB2002229B (en) Pharmaceutical composition
GB2008403B (en) Pharmaceutical compositions
PT68192A (en) Process for obtaining pharmaceutical compositions
ZA784470B (en) Pharmaceutical compositions including antithormbotic compositions
MW478A1 (en) Pharmaceutical compositions
DE2861944D1 (en) Pharmaceutical composition for administering choline
JPS5394038A (en) Pharmaceutical composition
JPS52120131A (en) Treating composition for rercholesterol disease
JPS5486607A (en) Solid pharmaceutical composition
JPS53101520A (en) Pharmaceutical composition
GB2008408B (en) Pharmaceutical compositions
JPS545045A (en) Pharmaceutical composition
GB1556851A (en) Pharmaceutical compositions
ZA782736B (en) Pharmaceutical compositions
JPS542338A (en) Pharmaceutical composition